FR2300573B1 - - Google Patents

Info

Publication number
FR2300573B1
FR2300573B1 FR7604293A FR7604293A FR2300573B1 FR 2300573 B1 FR2300573 B1 FR 2300573B1 FR 7604293 A FR7604293 A FR 7604293A FR 7604293 A FR7604293 A FR 7604293A FR 2300573 B1 FR2300573 B1 FR 2300573B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7604293A
Other languages
French (fr)
Other versions
FR2300573A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Serono Laboratories Inc
Original Assignee
Serono Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Laboratories Inc filed Critical Serono Laboratories Inc
Publication of FR2300573A1 publication Critical patent/FR2300573A1/fr
Application granted granted Critical
Publication of FR2300573B1 publication Critical patent/FR2300573B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/12General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by hydrolysis, i.e. solvolysis in general
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/59Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7604293A 1975-02-17 1976-02-17 Composition pharmaceutique a base de gonadotrophine chorionique humaine partiellement desialylee Granted FR2300573A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT48202/75A IT1057895B (it) 1975-02-17 1975-02-17 Gonadotropina corionica umana parzialmente desalinizzata per indurre l'ouvulazione

Publications (2)

Publication Number Publication Date
FR2300573A1 FR2300573A1 (fr) 1976-09-10
FR2300573B1 true FR2300573B1 (US20110009641A1-20110113-C00185.png) 1979-03-23

Family

ID=11265181

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7604293A Granted FR2300573A1 (fr) 1975-02-17 1976-02-17 Composition pharmaceutique a base de gonadotrophine chorionique humaine partiellement desialylee

Country Status (8)

Country Link
US (1) US4062942A (US20110009641A1-20110113-C00185.png)
BE (1) BE838657A (US20110009641A1-20110113-C00185.png)
CA (1) CA1059030A (US20110009641A1-20110113-C00185.png)
DE (1) DE2606309C3 (US20110009641A1-20110113-C00185.png)
FR (1) FR2300573A1 (US20110009641A1-20110113-C00185.png)
GB (1) GB1523825A (US20110009641A1-20110113-C00185.png)
IL (1) IL49054A (US20110009641A1-20110113-C00185.png)
IT (1) IT1057895B (US20110009641A1-20110113-C00185.png)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196123A (en) * 1978-11-20 1980-04-01 Eugenia Rosemberg Hybrid chorionic gonadotropin preparations and methods for stimulating ovulation using same
US4589402A (en) * 1984-07-26 1986-05-20 Serono Laboratories, Inc. Method of in vitro fertilization
US4970071A (en) * 1985-01-18 1990-11-13 Mcmichael John Immunotherapeutic methods and compositions employing antigens characteristic of non human malignant neoplasms
US4966753A (en) * 1987-08-18 1990-10-30 Molecular Rx, Inc. Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms
US5270057A (en) * 1990-03-20 1993-12-14 Akzo N.V. Stabilized gonadotropin containing preparations
US5384132A (en) * 1990-03-20 1995-01-24 Akzo N.V. Stabilized gonadotropin containing preparations
IE64738B1 (en) * 1990-03-20 1995-09-06 Akzo Nv Stabilized gonadotropin containing preparations
US5416071A (en) * 1991-03-12 1995-05-16 Takeda Chemical Industries, Ltd. Water-soluble composition for sustained-release containing epo and hyaluronic acid
HUT76660A (en) * 1994-01-20 1997-10-28 Akzo Nobel Nv New composition of glycoprotein isoforms having follicle stimulating activity
PL369606A1 (en) * 2001-10-22 2005-05-02 Applied Research Systems Ars Holding N.V. Gonadotrophins for folliculogenesis
CA2897658A1 (en) 2004-05-17 2005-12-22 The General Hospital Corporation Compositions comprising female germline stem cells and methods of use thereof
US7994131B2 (en) * 2004-10-07 2011-08-09 Stem Cell Therapeutics Corp. Stimulation of proliferation of pluripotential stem cells through administration of pregnancy associated compounds
EP2697365A4 (en) 2011-04-14 2014-07-23 Gen Hospital Corp COMPOSITIONS AND METHODS FOR AUTOLOGOUS ENERGY TRANSMISSION IN MITOCHONDRIAL GLAND LINES
EA201490050A1 (ru) 2011-06-29 2014-07-30 Зе Дженерэл Хоспитэл Корпорейшн Композиции и способы повышения биоэнергетического состояния женских зародышевых клеток

Also Published As

Publication number Publication date
DE2606309B2 (de) 1980-05-14
DE2606309A1 (de) 1976-08-26
IT1057895B (it) 1982-03-30
DE2606309C3 (de) 1981-01-22
IL49054A0 (en) 1976-04-30
GB1523825A (en) 1978-09-06
BE838657A (fr) 1976-08-17
IL49054A (en) 1979-09-30
CA1059030A (en) 1979-07-24
US4062942A (en) 1977-12-13
FR2300573A1 (fr) 1976-09-10

Similar Documents

Publication Publication Date Title
FR2300573B1 (US20110009641A1-20110113-C00185.png)
JPS5524548Y2 (US20110009641A1-20110113-C00185.png)
JPS5523419B2 (US20110009641A1-20110113-C00185.png)
JPS5519301B2 (US20110009641A1-20110113-C00185.png)
JPS5255882U (US20110009641A1-20110113-C00185.png)
JPS5224524U (US20110009641A1-20110113-C00185.png)
JPS5190806U (US20110009641A1-20110113-C00185.png)
JPS5241515Y2 (US20110009641A1-20110113-C00185.png)
JPS5235140U (US20110009641A1-20110113-C00185.png)
JPS5193346U (US20110009641A1-20110113-C00185.png)
JPS5229089U (US20110009641A1-20110113-C00185.png)
JPS5264292U (US20110009641A1-20110113-C00185.png)
JPS51143616U (US20110009641A1-20110113-C00185.png)
JPS51139059U (US20110009641A1-20110113-C00185.png)
CH577290A5 (US20110009641A1-20110113-C00185.png)
CH598923A5 (US20110009641A1-20110113-C00185.png)
CH583396A5 (US20110009641A1-20110113-C00185.png)
CH587405A5 (US20110009641A1-20110113-C00185.png)
CH587449A5 (US20110009641A1-20110113-C00185.png)
CH601890A5 (US20110009641A1-20110113-C00185.png)
CH588680A5 (US20110009641A1-20110113-C00185.png)
CH588775A5 (US20110009641A1-20110113-C00185.png)
CH589120A5 (US20110009641A1-20110113-C00185.png)
CH589804A5 (US20110009641A1-20110113-C00185.png)
CH599677A5 (US20110009641A1-20110113-C00185.png)